Cargando…
FDA remote evaluation of drug manufacturing during COVID-19
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062823/ http://dx.doi.org/10.1007/s40278-021-94456-0 |
Ejemplares similares
-
FDA and CDC recommend resuming use of Janssen COVID-19 vaccine
Publicado: (2021) -
FDA reports recall of Innova COVID-19 antigen rapid qualitative test
Publicado: (2021) -
COVID-19 pregnancy prevention guidance on teratogenic drugs
Publicado: (2020) -
Revisions of precautions for COVID-19 vaccines and other drugs in Japan
Publicado: (2021) -
Health Canada approves first drug for treatment of COVID-19
Publicado: (2020)